251 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S. http://www.zacks.com/stock/news/256531/eli-lillys-rheumatoid-arthritis-drug-gets-crl-in-the-us?cid=CS-ZC-FT-256531 Apr 17, 2017 - Eli Lilly and Company (LLY) and its partner Incyte Corporation (INCY) recently announced that they have received a Complete Response Letter (CRL) from the FDA regarding the new drug application (NDA) for baricitinib.
FDA Rejects Eli Lilly and Incyte Drug https://www.wsj.com/articles/fda-rejects-eli-lilly-and-incyte-rheumatoid-arthritis-drug-1492183825?mod=pls_whats_news_us_business_f Apr 14, 2017 - Eli Lilly and Incyte said the U.S. Food and Drug Administration didn’t approve their new drug application for a rheumatoid arthritis treatment that some analysts estimate could generate more than $2 billion in annual sales.
Surprise FDA Rejection Will Sting This Biotech https://www.wsj.com/articles/surprise-fda-rejection-will-sting-this-biotech-1492185721?mod=rss_markets_main Apr 14, 2017 - A Lilly-Incyte rheumatoid arthritis drug won’t come to market any time soon after the FDA’s surprise rejection of the treatment.
The IDO-Inhibitor Race Is On to Improve Cancer Treatment https://www.fool.com/investing/2017/04/13/the-ido-inhibitor-race-is-on-to-improve-cancer-tre.aspx?source=iedfolrf0000001 Apr 13, 2017 - NewLink Genetics and Incyte Corporation's IDO-inhibitors could be the next big advance in cancer treatment.
Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback http://www.zacks.com/stock/news/256108/biotech-stock-roundup-geron-gains-on-interim-data-oncomed-slumps-on-pipeline-setback?cid=CS-ZC-FT-256108 Apr 12, 2017 - Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.
Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals http://www.zacks.com/stock/news/254822/zackscom-featured-highlights-ptc-covanta-holding-etsy-incyte-and-amag-pharmaceuticals?cid=CS-ZC-FT-254822 Mar 31, 2017 - Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals
5 Toxic Stocks to Get Rid Of or Play Short to Make Gains http://www.zacks.com/stock/news/254716/5-toxic-stocks-to-get-rid-of-or-play-short-to-make-gains?cid=CS-ZC-FT-254716 Mar 30, 2017 - Exaggerated price of toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacuna.
Incyte (INCY) Up 26.2% Since Earnings Report: Can It Continue? http://www.zacks.com/stock/news/253120/incyte-incy-up-262-since-earnings-report-can-it-continue?cid=CS-ZC-FT-253120 Mar 17, 2017 - Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals http://www.zacks.com/stock/news/253076/zackscom-featured-highlights-covanta-holding-etsy-ptc-incyte-and-vertex-pharmaceuticals?cid=CS-ZC-FT-253076 Mar 16, 2017 - Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data http://www.zacks.com/stock/news/252975/biotech-stock-roundup-amgens-data-on-repatha-catalyst-soars-on-firdapse-data?cid=CS-ZC-FT-252975 Mar 16, 2017 - The biotech sector reacted favorably to President Donald Trump's pick for the top post in the FDA.

Pages: 1...181920212223242526

<<<Page 23>